Related Experiment Video
Updated: Nov 15, 2025

A Detailed Protocol for Perspiration Monitoring Using a Novel, Small, Wireless Device
Published on: November 24, 2016
Primary hyperhidrosis in children: A review of therapeutics
Courtney Remington1, Jennifer Ruth2,3, Adelaide A Hebert4
1The University of Texas Rio Grande Valley School of Medicine, Edinburg, TX, USA.
Insights
Primary hyperhidrosis causes excessive sweating in children and teens, impacting well-being. This review covers current and emerging treatments for this common condition.
Area of Science:
- Dermatology
- Pediatrics
Background:
- Primary hyperhidrosis is a condition causing excessive sweating beyond physiological needs.
- It typically begins in childhood or adolescence, affecting quality of life.
Purpose of the Study:
- To review current therapeutic options for primary hyperhidrosis in pediatric patients.
- To identify emerging treatments and research needs for this condition.
Main Methods:
- Literature review of existing therapeutic options.
- Exploration of topical, oral, procedural, and adjunctive therapies.
- Identification of novel and developing treatment strategies.
Main Results:
- Various treatment modalities exist for pediatric primary hyperhidrosis.
- New and emerging treatments show promise for managing the condition.
- Further research is needed to expand therapeutic options.
Conclusions:
- Effective management strategies for pediatric primary hyperhidrosis are available.
- Ongoing research and development are crucial for improving patient outcomes.
- Addressing the multifaceted impact of hyperhidrosis on well-being is essential.
Abstract:
Primary hyperhidrosis, an idiopathic disease that commonly affects the palms, soles, axillae, or craniofacial region, is characterized by perspiration in excess of what is required for physiologic cooling. This disease begins in childhood or adolescence and negatively impacts emotional, physical, and psychologic well-being. This review explores current therapeutic options for primary hyperhidrosis in the pediatric population, including topical therapies, oral therapies, non-surgical and procedural interventions, and adjunctive therapies. In addition, this review identifies new and emerging treatments and highlights the need for further research and therapeutic options for this impactful disease.
Related Concept Videos
Accessory Structures of the Skin: Sweat Glands
Sweat glands are classified as merocrine glands; that is, the secretions are excreted by exocytosis through a duct without affecting the cells of the gland. There...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Direct-Acting Cholinergic Agonists: Therapeutic Uses

